161 related articles for article (PubMed ID: 37537884)
1. Rapid reduction of adenomyosis coexisting with leiomyoma volume during treatment with Relugolix.
Yamanaka K; Washio K; Uchida A; Sasagawa Y; Nishimoto M; Yamasaki Y; Nagamata S; Terai Y
Gynecol Endocrinol; 2023 Dec; 39(1):2237121. PubMed ID: 37537884
[TBL] [Abstract][Full Text] [Related]
2. LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids.
Al-Hendy A; Venturella R; Arjona Ferreira JC; Li Y; Soulban G; Wagman RB; Lukes AS
Am J Obstet Gynecol; 2023 Dec; 229(6):662.e1-662.e25. PubMed ID: 37666383
[TBL] [Abstract][Full Text] [Related]
3. Relugolix combination therapy in Black/African American women with symptomatic uterine fibroids: LIBERTY Long-Term Extension study.
Stewart EA; Al-Hendy A; Lukes AS; Madueke-Laveaux OS; Zhu E; Proehl S; Schulmann T; Marsh EE
Am J Obstet Gynecol; 2024 Feb; 230(2):237.e1-237.e11. PubMed ID: 37863160
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.
Al-Hendy A; Lukes AS; Poindexter AN; Venturella R; Villarroel C; Critchley HOD; Li Y; McKain L; Arjona Ferreira JC; Langenberg AGM; Wagman RB; Stewart EA
N Engl J Med; 2021 Feb; 384(7):630-642. PubMed ID: 33596357
[TBL] [Abstract][Full Text] [Related]
5. A case of adenomyosis with leiomyoma that was effectively treated with relugolix and kamishoyosan add-on therapy.
Sasamori Y; Takehara K; Terashima T; Onodera T; Yatsuki K; Nakagawa I; Takahashi Y; Nishida H; Ichinose T; Hiraike H; Nagasaka K
BMC Womens Health; 2021 Aug; 21(1):306. PubMed ID: 34412607
[TBL] [Abstract][Full Text] [Related]
6. Quality of life with relugolix combination therapy for uterine fibroids: LIBERTY randomized trials.
Stewart EA; Lukes AS; Venturella R; Li Y; Hunsche E; Wagman RB; Al-Hendy A
Am J Obstet Gynecol; 2023 Mar; 228(3):320.e1-320.e11. PubMed ID: 36370871
[TBL] [Abstract][Full Text] [Related]
7. Ulipristal Acetate Improves Clinical Symptoms in Women with Adenomyosis and Uterine Myomas.
Gracia M; Alcalà M; Ferreri J; Rius M; Ros C; Saco MA; Martínez-Zamora MÁ; Carmona F
J Minim Invasive Gynecol; 2018; 25(7):1274-1280. PubMed ID: 29626678
[TBL] [Abstract][Full Text] [Related]
8. Clinical analysis of acute postoperative pain after total laparoscopic hysterectomy for adenomyosis and uterine fibroids - a prospective observational study.
Wu Q; Zhou Y; Sun S; Li H; Cao S; Shou H
Ann Med; 2023; 55(2):2281510. PubMed ID: 37994446
[TBL] [Abstract][Full Text] [Related]
9. 500 Cases of High-intensity Focused Ultrasound (HIFU) Ablated Uterine Fibroids and Adenomyosis.
Jeng CJ; Ou KY; Long CY; Chuang L; Ker CR
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):865-871. PubMed ID: 33218403
[TBL] [Abstract][Full Text] [Related]
10. Understanding clinical features of adenomyosis: a case control study.
Shrestha A; Sedai LB
Nepal Med Coll J; 2012 Sep; 14(3):176-9. PubMed ID: 24047010
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of the selective progesterone receptor modulator asoprisnil for heavy menstrual bleeding with uterine fibroids: pooled analysis of two 12-month, placebo-controlled, randomized trials.
Stewart EA; Diamond MP; Williams ARW; Carr BR; Myers ER; Feldman RA; Elger W; Mattia-Goldberg C; Schwefel BM; Chwalisz K
Hum Reprod; 2019 Apr; 34(4):623-634. PubMed ID: 30865281
[TBL] [Abstract][Full Text] [Related]
12. Selective progesterone receptor modulators (SPRMs) for uterine fibroids.
Murji A; Whitaker L; Chow TL; Sobel ML
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD010770. PubMed ID: 28444736
[TBL] [Abstract][Full Text] [Related]
13. The effect of exercise on high-intensity focused ultrasound treatment efficacy in uterine fibroids and adenomyosis: a retrospective study.
Huang X; Yu D; Zou M; Wang L; Xing HR; Wang Z
BJOG; 2017 Aug; 124 Suppl 3():46-52. PubMed ID: 28856860
[TBL] [Abstract][Full Text] [Related]
14. Preoperative medical therapy before surgery for uterine fibroids.
Lethaby A; Puscasiu L; Vollenhoven B
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD000547. PubMed ID: 29139105
[TBL] [Abstract][Full Text] [Related]
15. Safety of ultrasound-guided ultrasound ablation for uterine fibroids and adenomyosis: A review of 9988 cases.
Chen J; Chen W; Zhang L; Li K; Peng S; He M; Hu L
Ultrason Sonochem; 2015 Nov; 27():671-676. PubMed ID: 26093678
[TBL] [Abstract][Full Text] [Related]
16. Long-term Relugolix Combination Therapy for Symptomatic Uterine Leiomyomas.
Al-Hendy A; Lukes AS; Poindexter AN; Venturella R; Villarroel C; McKain L; Li Y; Wagman RB; Stewart EA
Obstet Gynecol; 2022 Dec; 140(6):920-930. PubMed ID: 36357960
[TBL] [Abstract][Full Text] [Related]
17. [Preoperative treatment of uterine fibroids with low-dose mifepristone: a multicenter, randomized, double-blind, placebo-controlled, parallel-group study].
Bian ML; Huang ML; Zhang ZY; Liu SM; Sun J; Fang F; Gu YP; Liu CD; Yao C
Zhonghua Fu Chan Ke Za Zhi; 2021 May; 56(5):317-327. PubMed ID: 34034418
[No Abstract] [Full Text] [Related]
18. Long-term treatment of uterine fibroids with ulipristal acetate ☆.
Donnez J; Vázquez F; Tomaszewski J; Nouri K; Bouchard P; Fauser BC; Barlow DH; Palacios S; Donnez O; Bestel E; Osterloh I; Loumaye E;
Fertil Steril; 2014 Jun; 101(6):1565-73.e1-18. PubMed ID: 24630081
[TBL] [Abstract][Full Text] [Related]
19. Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids.
Lethaby A; Vollenhoven B; Sowter M
Cochrane Database Syst Rev; 2001; (2):CD000547. PubMed ID: 11405968
[TBL] [Abstract][Full Text] [Related]
20. Relugolix/Estradiol/Norethisterone (Norethindrone) Acetate: A Review in Symptomatic Uterine Fibroids.
Syed YY
Drugs; 2022 Oct; 82(15):1549-1556. PubMed ID: 36331779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
